|
Issued: Friday, 10th September 2010, London, U.K.
GSK publishes historical quarterly turnover by product. |
For the reporting period ended 30th June 2010, GlaxoSmithKline (GSK) adopted a revised presentation for the analysis of its pharmaceutical turnover by product and therapeutic area that identified the revenues from the Emerging Markets segment separately from the Rest of World. In order to assist comparability with historically published data, this release includes the pharmaceutical turnover by product for each quarter since the period ended 31st March 2008 presented on a like-for-like basis with the information for the period ended 30th June 2010.
This information differs from the previously published information for presentational reasons only, including principally:
· The separation of the Emerging Markets segment product revenues from Rest of World;
· The creation of the new Dermatological therapeutic area and the reclassification of certain products into this category from previously reported categories;
· The creation of ViiV Healthcare in 2009.
S M Bicknell
Company Secretary
10 September 2010
|
GlaxoSmithKline (GSK) together with its subsidiary undertakings, the 'Group' - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com |
Enquiries:
|
UK Media |
David Mawdsley Claire Brough Alexandra Harrison Stephen Rea Jo Revill |
(020) 8047 5564 (020) 8047 5502 (020) 8047 5502 (020) 8047 5502 (020) 8047 5502 |
|
|
|
|
|
US Media |
Nancy Pekarek Mary Anne Rhyne Kevin Colgan Sarah Alspach |
(919) 483 2839 (919) 483 2839 (919) 483 2839 (919) 483 2839 |
|
|
|
|
|
European Analyst / Investor |
Sally Ferguson Gary Davies |
(020) 8047 5543 (020) 8047 5503 |
|
US Analyst / Investor |
Tom Curry Jen Hill Baxter |
(215) 751 5419 (215) 751 7002 |
|
CER growth In order to illustrate underlying performance, it is the Group's practice to discuss its results in terms of constant exchange rate (CER) growth. This represents growth calculated as if the exchange rates used to determine the results of overseas companies in Sterling had remained unchanged from those used in the comparative period. |
Brand names and partner acknowledgements Brand names appearing in italics throughout this document are trademarks of GSK or associated companies or used under licence by the Group. |
|
This Announcement does not constitute statutory accounts of the Group within the meaning of sections 434(3) and 435(3) of the Companies Act 2006. The information for 2008 and 2009 has been derived from the full Group accounts published in the Annual Report 2008 and 2009, which has been delivered to the Registrar of Companies and on which the report of the independent auditors was unqualified and did not contain a statement under section 498 of the Companies Act 2006.
Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2009.
GlaxoSmithKline plc, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom Registered in England and Wales. Registered number: 3888792 |
Pharmaceuticals turnover |
Three months ended 31st March 2010 |
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
|||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
|
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
|
Respiratory |
1,766 |
6 |
805 |
3 |
569 |
6 |
143 |
30 |
249 |
4 |
|
|
Avamys/Veramyst |
46 |
52 |
17 |
(10) |
13 |
56 |
5 |
>100 |
11 |
>100 |
|
|
Flixonase/Flonase |
45 |
(30) |
6 |
(40) |
10 |
(17) |
9 |
13 |
20 |
(41) |
|
|
Flixotide/Flovent |
196 |
5 |
99 |
8 |
45 |
(6) |
14 |
75 |
38 |
(5) |
|
|
Seretide/Advair |
1,264 |
9 |
630 |
4 |
423 |
10 |
80 |
28 |
131 |
23 |
|
|
Serevent |
51 |
(16) |
16 |
(11) |
26 |
(16) |
- |
- |
9 |
(18) |
|
|
Ventolin |
116 |
3 |
35 |
- |
37 |
- |
24 |
14 |
20 |
- |
|
|
Zyrtec |
20 |
17 |
- |
- |
- |
- |
2 |
100 |
18 |
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-virals |
358 |
(44) |
154 |
(42) |
35 |
(78) |
47 |
9 |
122 |
(27) |
|
|
Hepsera |
29 |
11 |
- |
- |
- |
- |
12 |
- |
17 |
21 |
|
|
Relenza |
84 |
(60) |
30 |
>100 |
2 |
(97) |
1 |
- |
51 |
(49) |
|
|
Valtrex |
176 |
(46) |
107 |
(55) |
23 |
(43) |
5 |
- |
41 |
- |
|
|
Zeffix |
52 |
4 |
3 |
- |
7 |
- |
29 |
11 |
13 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Central nervous system |
417 |
(13) |
136 |
(32) |
140 |
(2) |
45 |
14 |
96 |
3 |
|
|
Imigran/Imitrex |
57 |
(9) |
24 |
(11) |
22 |
(12) |
1 |
- |
10 |
- |
|
|
Lamictal |
120 |
(11) |
61 |
(23) |
37 |
(3) |
12 |
8 |
10 |
67 |
|
|
Requip |
55 |
14 |
10 |
38 |
36 |
13 |
- |
- |
9 |
- |
|
|
Seroxat/Paxil |
106 |
(12) |
10 |
(29) |
22 |
(21) |
15 |
- |
59 |
(7) |
|
|
Treximet |
13 |
7 |
13 |
7 |
- |
- |
- |
- |
- |
- |
|
|
Wellbutrin |
20 |
(67) |
8 |
(85) |
9 |
50 |
3 |
50 |
- |
(50) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiovascular and urogenital |
570 |
9 |
337 |
6 |
153 |
11 |
28 |
25 |
52 |
21 |
|
|
Arixtra |
70 |
25 |
39 |
27 |
26 |
23 |
2 |
100 |
3 |
- |
|
|
Avodart |
139 |
20 |
76 |
12 |
40 |
17 |
7 |
60 |
16 |
88 |
|
|
Coreg |
42 |
(12) |
42 |
(12) |
- |
- |
- |
- |
- |
- |
|
|
Fraxiparine |
56 |
4 |
- |
- |
43 |
- |
11 |
22 |
2 |
- |
|
|
Lovaza |
107 |
9 |
107 |
10 |
- |
- |
- |
- |
- |
- |
|
|
Vesicare |
25 |
13 |
25 |
13 |
- |
- |
- |
- |
- |
- |
|
|
Volibris |
9 |
>100 |
- |
- |
8 |
>100 |
- |
- |
1 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metabolic |
230 |
(18) |
89 |
(36) |
61 |
(7) |
31 |
18 |
49 |
2 |
|
|
Avandia products |
169 |
(10) |
89 |
(14) |
38 |
(12) |
19 |
6 |
23 |
4 |
|
|
Bonviva/Boniva |
23 |
(63) |
- |
- |
20 |
(5) |
- |
- |
3 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-bacterials |
356 |
(6) |
24 |
(10) |
142 |
(21) |
146 |
11 |
44 |
5 |
|
|
Augmentin |
160 |
(10) |
8 |
(44) |
63 |
(23) |
70 |
12 |
19 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oncology and emesis |
169 |
23 |
92 |
41 |
50 |
- |
12 |
8 |
15 |
27 |
|
|
Arzerra |
5 |
- |
5 |
- |
- |
- |
- |
- |
- |
- |
|
|
Hycamtin |
40 |
- |
24 |
- |
13 |
(7) |
2 |
100 |
1 |
- |
|
|
Promacta |
6 |
>100 |
6 |
>100 |
- |
- |
- |
- |
- |
- |
|
|
Tyverb/Tykerb |
53 |
62 |
17 |
73 |
24 |
41 |
5 |
67 |
7 |
>100 |
|
|
Votrient |
5 |
- |
5 |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines |
1,411 |
>100 |
171 |
55 |
613 |
>100 |
272 |
>100 |
355 |
>100 |
|
|
Boostrix |
30 |
19 |
15 |
55 |
9 |
25 |
2 |
100 |
4 |
(67) |
|
|
Cervarix |
77 |
60 |
2 |
- |
59 |
51 |
4 |
(33) |
12 |
>100 |
|
|
Fluarix, FluLaval |
5 |
(43) |
1 |
- |
- |
- |
- |
(100) |
4 |
>100 |
|
|
Flu Pandemic |
698 |
>100 |
- |
- |
304 |
>100 |
152 |
- |
242 |
>100 |
|
|
Hepatitis |
197 |
38 |
92 |
92 |
61 |
2 |
20 |
17 |
24 |
22 |
|
|
Infanrix, Pediarix |
166 |
(3) |
32 |
(13) |
104 |
(2) |
10 |
(8) |
20 |
13 |
|
|
Rotarix |
65 |
19 |
27 |
93 |
13 |
8 |
17 |
(25) |
8 |
40 |
|
|
Synflorix |
45 |
- |
- |
- |
12 |
- |
26 |
- |
7 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dermatologicals |
265 |
>100 |
97 |
>100 |
62 |
>100 |
62 |
75 |
44 |
95 |
|
|
Bactroban |
27 |
(7) |
11 |
(20) |
6 |
- |
6 |
(14) |
4 |
100 |
|
|
Dermovate |
15 |
- |
- |
- |
4 |
- |
5 |
- |
6 |
- |
|
|
Duac |
27 |
- |
17 |
- |
6 |
- |
3 |
- |
1 |
- |
|
|
Soriatane |
18 |
- |
18 |
- |
- |
- |
- |
- |
- |
- |
|
|
Zovirax |
49 |
61 |
26 |
>100 |
7 |
(13) |
6 |
- |
10 |
(17) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
211 |
20 |
4 |
(20) |
68 |
24 |
80 |
30 |
59 |
11 |
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
5,753 |
15 |
1,909 |
(1) |
1,893 |
16 |
866 |
43 |
1,085 |
35 |
|
|
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
ViiV Healthcare (HIV) |
373 |
(7) |
159 |
(11) |
159 |
(3) |
18 |
- |
37 |
(5) |
|
|
Combivir |
82 |
(23) |
34 |
(30) |
33 |
(17) |
6 |
(33) |
9 |
- |
|
|
Epivir |
28 |
(15) |
10 |
(15) |
10 |
(21) |
3 |
50 |
5 |
(20) |
|
|
Epzicom/Kivexa |
131 |
(1) |
48 |
(10) |
64 |
6 |
2 |
- |
17 |
7 |
|
|
Lexiva |
41 |
(8) |
21 |
(15) |
15 |
(12) |
2 |
>100 |
3 |
- |
|
|
Selzentry |
19 |
- |
8 |
- |
11 |
- |
- |
- |
- |
- |
|
|
Trizivir |
38 |
(27) |
19 |
(33) |
17 |
(29) |
1 |
- |
1 |
>100 |
|
|
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
6,126 |
14 |
|
|
|
|
|
|
|
|
|
|
|
------ |
------ |
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals turnover |
||||||||||||
Three months ended 31st December 2009 |
||||||||||||
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
||||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
|||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
||
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
||
Respiratory |
1,914 |
7 |
910 |
5 |
594 |
4 |
135 |
17 |
275 |
17 |
|
||
Avamys/Veramyst |
33 |
36 |
15 |
(17) |
11 |
83 |
4 |
>100 |
3 |
- |
|
||
Flixonase/Flonase |
35 |
(14) |
6 |
(25) |
10 |
(17) |
8 |
- |
11 |
(14) |
|
||
Flixotide/Flovent |
222 |
3 |
115 |
9 |
49 |
(4) |
9 |
- |
49 |
(2) |
|
||
Seretide/Advair |
1,366 |
7 |
704 |
3 |
436 |
7 |
72 |
18 |
154 |
26 |
|
||
Serevent |
61 |
(14) |
20 |
(9) |
29 |
(15) |
1 |
- |
11 |
(21) |
|
||
Ventolin |
139 |
28 |
48 |
100 |
42 |
- |
25 |
9 |
24 |
22 |
|
||
Zyrtec |
22 |
67 |
- |
- |
- |
- |
4 |
>100 |
18 |
55 |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Anti-virals |
583 |
20 |
211 |
(25) |
88 |
63 |
67 |
48 |
217 |
>100 |
|
||
Hepsera |
30 |
7 |
- |
- |
- |
- |
13 |
8 |
17 |
7 |
|
||
Relenza |
256 |
>100 |
62 |
>100 |
39 |
>100 |
17 |
- |
138 |
>100 |
|
||
Valtrex |
222 |
(34) |
129 |
(45) |
41 |
5 |
8 |
33 |
44 |
(9) |
|
||
Zeffix |
55 |
- |
4 |
- |
7 |
(14) |
29 |
12 |
15 |
(13) |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Central nervous system |
504 |
(27) |
178 |
(50) |
146 |
(7) |
50 |
24 |
130 |
(3) |
|
||
Imigran/Imitrex |
81 |
(50) |
43 |
(64) |
25 |
(8) |
2 |
- |
11 |
- |
|
||
Lamictal |
132 |
(27) |
72 |
(40) |
39 |
(5) |
12 |
- |
9 |
29 |
|
||
Requip |
65 |
3 |
16 |
27 |
37 |
(8) |
1 |
- |
11 |
11 |
|
||
Seroxat/Paxil |
139 |
(16) |
10 |
(47) |
22 |
(24) |
19 |
5 |
88 |
(10) |
|
||
Treximet |
14 |
15 |
14 |
8 |
- |
- |
- |
- |
- |
- |
|
||
Wellbutrin |
22 |
(64) |
10 |
(79) |
9 |
33 |
3 |
50 |
- |
(50) |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Cardiovascular and urogenital |
615 |
10 |
375 |
8 |
155 |
8 |
29 |
30 |
56 |
23 |
|
||
Arixtra |
74 |
31 |
43 |
35 |
26 |
14 |
2 |
100 |
3 |
100 |
|
||
Avodart |
143 |
16 |
83 |
11 |
39 |
12 |
6 |
75 |
15 |
50 |
|
||
Coreg |
31 |
(46) |
31 |
(45) |
- |
- |
- |
- |
- |
- |
|
||
Fraxiparine |
60 |
2 |
- |
- |
45 |
- |
12 |
20 |
3 |
(25) |
|
||
Lovaza |
129 |
29 |
128 |
29 |
- |
- |
- |
- |
1 |
- |
|
||
Vesicare |
29 |
26 |
29 |
26 |
- |
- |
- |
- |
- |
- |
|
||
Volibris |
7 |
>100 |
- |
- |
7 |
>100 |
- |
- |
- |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Metabolic |
300 |
(15) |
150 |
(18) |
69 |
(13) |
28 |
(13) |
53 |
(7) |
|
||
Avandia products |
191 |
(17) |
109 |
(17) |
40 |
(17) |
17 |
(23) |
25 |
(14) |
|
||
Bonviva/Boniva |
67 |
(13) |
41 |
(20) |
23 |
(4) |
1 |
- |
2 |
100 |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Anti-bacterials |
378 |
3 |
24 |
(16) |
176 |
(2) |
138 |
18 |
40 |
(5) |
|
||
Augmentin |
173 |
7 |
9 |
(33) |
82 |
7 |
62 |
23 |
20 |
(6) |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Oncology and emesis |
170 |
17 |
86 |
30 |
52 |
- |
15 |
27 |
17 |
15 |
|
||
Arzerra |
3 |
- |
3 |
- |
- |
- |
- |
- |
- |
- |
|
||
Hycamtin |
45 |
7 |
26 |
4 |
15 |
7 |
1 |
100 |
3 |
- |
|
||
Promacta |
5 |
- |
5 |
- |
- |
- |
- |
- |
- |
- |
|
||
Tyverb/Tykerb |
48 |
29 |
14 |
(7) |
21 |
12 |
6 |
50 |
7 |
- |
|
||
Votrient |
1 |
- |
1 |
- |
- |
- |
- |
- |
- |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Vaccines |
1,523 |
78 |
294 |
55 |
794 |
>100 |
229 |
28 |
206 |
>100 |
|
||
Boostrix |
35 |
100 |
17 |
>100 |
11 |
57 |
1 |
- |
6 |
>100 |
|
||
Cervarix |
38 |
(33) |
4 |
- |
19 |
(58) |
7 |
- |
8 |
>100 |
|
||
Fluarix, FluLaval |
42 |
(33) |
5 |
(64) |
11 |
(43) |
14 |
- |
12 |
8 |
|
||
Flu Pandemic |
836 |
>100 |
162 |
>100 |
511 |
>100 |
55 |
- |
108 |
>100 |
|
||
Hepatitis |
151 |
(19) |
51 |
(27) |
64 |
(16) |
18 |
(10) |
18 |
(6) |
|
||
Infanrix, Pediarix |
153 |
(24) |
27 |
(50) |
101 |
(14) |
9 |
(11) |
16 |
(6) |
|
||
Rotarix |
70 |
5 |
17 |
- |
14 |
8 |
33 |
3 |
6 |
25 |
|
||
Synflorix |
48 |
- |
- |
- |
11 |
- |
31 |
- |
6 |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Dermatologicals |
255 |
>100 |
91 |
29 |
56 |
(10) |
57 |
7 |
51 |
>100 |
|
||
Bactroban |
28 |
(7) |
14 |
(8) |
6 |
(21) |
6 |
12 |
2 |
(3) |
|
||
Dermovate |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
Duac |
23 |
- |
15 |
- |
6 |
- |
1 |
- |
1 |
- |
|
||
Soriatane |
16 |
- |
16 |
- |
- |
- |
- |
- |
- |
- |
|
||
Zovirax |
38 |
(23) |
13 |
>100 |
7 |
(13) |
5 |
- |
13 |
(14) |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Other |
256 |
20 |
3 |
67 |
100 |
14 |
69 |
26 |
84 |
19 |
|
||
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
||
|
6,498 |
16 |
2,322 |
(4) |
2,230 |
26 |
817 |
22 |
1,129 |
52 |
|
||
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
||
ViiV Healthcare (HIV) |
412 |
(3) |
189 |
(3) |
155 |
(10) |
30 |
24 |
38 |
3 |
|
||
Combivir |
109 |
(5) |
47 |
(9) |
37 |
(14) |
15 |
50 |
10 |
- |
|
||
Epivir |
30 |
(17) |
12 |
(7) |
11 |
(27) |
2 |
100 |
5 |
(33) |
|
||
Epzicom/Kivexa |
149 |
11 |
63 |
13 |
63 |
5 |
6 |
20 |
17 |
25 |
|
||
Lexiva |
44 |
(9) |
25 |
(4) |
14 |
(7) |
2 |
(60) |
3 |
100 |
|
||
Selzentry |
1 |
- |
- |
- |
1 |
- |
- |
- |
- |
- |
|
||
Trizivir |
49 |
(19) |
26 |
(19) |
19 |
(18) |
3 |
50 |
1 |
(67) |
|
||
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
||
|
6,910 |
15 |
|
|
|
|
|
|
|
|
|
||
|
------ |
------ |
|
|
|
|
|
|
|
|
|
||
Pharmaceuticals turnover |
|
||||||||||||
Three months ended 30th September 2009 |
|
||||||||||||
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
||||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
|||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
||
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
||
Respiratory |
1,594 |
6 |
744 |
2 |
511 |
7 |
127 |
34 |
212 |
3 |
|
||
Avamys/Veramyst |
31 |
59 |
15 |
8 |
9 |
>100 |
3 |
- |
4 |
- |
|
||
Flixonase/Flonase |
28 |
(21) |
3 |
(57) |
9 |
(18) |
9 |
- |
7 |
(14) |
|
||
Flixotide/Flovent |
169 |
- |
85 |
4 |
38 |
(5) |
9 |
33 |
37 |
(9) |
|
||
Seretide/Advair |
1,152 |
5 |
587 |
(1) |
378 |
9 |
66 |
25 |
121 |
10 |
|
||
Serevent |
54 |
(18) |
16 |
(18) |
27 |
(16) |
- |
- |
11 |
(30) |
|
||
Ventolin |
110 |
28 |
35 |
>100 |
35 |
3 |
22 |
29 |
18 |
(24) |
|
||
Zyrtec |
18 |
>100 |
- |
- |
- |
- |
6 |
>100 |
12 |
67 |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Anti-virals |
630 |
38 |
328 |
17 |
85 |
86 |
60 |
55 |
157 |
72 |
|
||
Hepsera |
28 |
25 |
- |
- |
- |
- |
12 |
25 |
16 |
17 |
|
||
Relenza |
182 |
>100 |
45 |
>100 |
38 |
- |
13 |
- |
86 |
>100 |
|
||
Valtrex |
349 |
(1) |
265 |
3 |
38 |
(3) |
6 |
- |
40 |
(18) |
|
||
Zeffix |
54 |
14 |
4 |
- |
7 |
- |
29 |
20 |
14 |
18 |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Central nervous system |
418 |
(37) |
115 |
(67) |
139 |
(9) |
51 |
30 |
113 |
4 |
|
||
Imigran/Imitrex |
53 |
(74) |
19 |
(89) |
23 |
(8) |
1 |
- |
10 |
(11) |
|
||
Lamictal |
121 |
(21) |
64 |
(35) |
38 |
(5) |
11 |
- |
8 |
60 |
|
||
Requip |
43 |
(30) |
(4) |
- |
34 |
(9) |
- |
- |
13 |
29 |
|
||
Seroxat/Paxil |
120 |
(12) |
5 |
(54) |
22 |
(26) |
19 |
13 |
74 |
(2) |
|
||
Treximet |
15 |
>100 |
15 |
>100 |
- |
- |
- |
- |
- |
- |
|
||
Wellbutrin |
16 |
(70) |
4 |
(86) |
8 |
33 |
3 |
- |
1 |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Cardiovascular and urogenital |
552 |
5 |
336 |
4 |
142 |
2 |
28 |
33 |
46 |
3 |
|
||
Arixtra |
60 |
20 |
32 |
23 |
24 |
11 |
2 |
- |
2 |
100 |
|
||
Avodart |
131 |
14 |
80 |
10 |
36 |
10 |
6 |
50 |
9 |
50 |
|
||
Coreg |
39 |
(30) |
39 |
(31) |
- |
- |
- |
- |
- |
- |
|
||
Fraxiparine |
56 |
(12) |
- |
- |
42 |
(15) |
11 |
10 |
3 |
(50) |
|
||
Lovaza |
111 |
27 |
111 |
24 |
- |
- |
- |
- |
- |
- |
|
||
Vesicare |
25 |
17 |
25 |
17 |
- |
- |
- |
- |
- |
- |
|
||
Volibris |
6 |
>100 |
- |
- |
5 |
>100 |
- |
- |
1 |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Metabolic |
284 |
(13) |
132 |
(15) |
67 |
(14) |
31 |
(9) |
54 |
(10) |
|
||
Avandia products |
185 |
(14) |
97 |
(14) |
42 |
(19) |
20 |
12 |
26 |
(22) |
|
||
Bonviva/Boniva |
60 |
(5) |
35 |
(17) |
22 |
11 |
- |
- |
3 |
50 |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Anti-bacterials |
340 |
4 |
22 |
(15) |
137 |
(4) |
138 |
19 |
43 |
1 |
|
||
Augmentin |
162 |
8 |
9 |
(22) |
68 |
2 |
68 |
18 |
17 |
13 |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Oncology and emesis |
149 |
4 |
64 |
(11) |
51 |
15 |
16 |
50 |
18 |
8 |
|
||
Arzerra |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
Hycamtin |
41 |
9 |
24 |
- |
14 |
8 |
2 |
- |
1 |
>100 |
|
||
Promacta |
3 |
- |
3 |
- |
- |
- |
- |
- |
- |
- |
|
||
Tyverb/Tykerb |
46 |
54 |
12 |
(8) |
19 |
90 |
7 |
>100 |
8 |
100 |
|
||
Votrient |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Vaccines |
802 |
(2) |
206 |
(20) |
344 |
(3) |
164 |
30 |
88 |
5 |
|
||
Boostrix |
39 |
55 |
24 |
54 |
11 |
43 |
- |
- |
4 |
50 |
|
||
Cervarix |
28 |
(40) |
- |
- |
17 |
(61) |
6 |
>100 |
5 |
100 |
|
||
Fluarix, FluLaval |
147 |
(14) |
63 |
(20) |
60 |
(10) |
14 |
8 |
10 |
(25) |
|
||
Flu Pandemic |
11 |
- |
- |
- |
4 |
(60) |
- |
- |
7 |
- |
|
||
Hepatitis |
170 |
(12) |
67 |
(29) |
65 |
- |
22 |
31 |
16 |
(13) |
|
||
Infanrix, Pediarix |
167 |
(10) |
30 |
(52) |
105 |
8 |
15 |
40 |
17 |
8 |
|
||
Rotarix |
84 |
92 |
22 |
>100 |
14 |
9 |
43 |
100 |
5 |
20 |
|
||
Synflorix |
13 |
- |
- |
- |
11 |
- |
1 |
- |
1 |
- |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Dermatologicals |
220 |
84 |
74 |
(13) |
52 |
(6) |
52 |
7 |
42 |
>100 |
|
||
Bactroban |
33 |
1 |
15 |
(6) |
7 |
(4) |
7 |
13 |
4 |
34 |
|
||
Dermovate |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
Duac |
23 |
- |
15 |
- |
4 |
- |
2 |
- |
2 |
- |
|
||
Soriatane |
12 |
- |
12 |
- |
- |
- |
- |
- |
- |
- |
|
||
Zovirax |
27 |
(4) |
4 |
- |
7 |
(14) |
5 |
20 |
11 |
(10) |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
Other |
204 |
20 |
7 |
(75) |
70 |
34 |
79 |
45 |
48 |
(5) |
|
||
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
||
|
5,193 |
3 |
2,028 |
(12) |
1,598 |
4 |
746 |
28 |
821 |
24 |
|
||
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
||
ViiV Healthcare (HIV) |
395 |
(7) |
168 |
(5) |
154 |
(6) |
33 |
(16) |
40 |
(3) |
|
||
Combivir |
102 |
(15) |
43 |
(10) |
36 |
(13) |
14 |
(29) |
9 |
(10) |
|
||
Epivir |
34 |
(14) |
12 |
(9) |
12 |
(15) |
6 |
(14) |
4 |
(25) |
|
||
Epzicom/Kivexa |
131 |
6 |
52 |
2 |
60 |
10 |
6 |
100 |
13 |
(15) |
|
||
Lexiva |
43 |
(3) |
24 |
- |
15 |
(7) |
2 |
- |
2 |
- |
|
||
Selzentry |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
||
Trizivir |
48 |
(12) |
23 |
(13) |
19 |
(23) |
3 |
>100 |
3 |
- |
|
||
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
||
|
5,588 |
2 |
|
|
|
|
|
|
|
|
|
||
|
------ |
------ |
|
|
|
|
|
|
|
|
|
||
Pharmaceuticals turnover |
|
||||||||||||
Three months ended 30th June 2009 |
|
||||||||||||
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
|||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
|
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
|
Respiratory |
1,734 |
6 |
825 |
5 |
550 |
2 |
133 |
21 |
226 |
12 |
|
|
Avamys/Veramyst |
47 |
>100 |
18 |
7 |
16 |
>100 |
3 |
- |
10 |
>100 |
|
|
Flixonase/Flonase |
39 |
(46) |
8 |
(82) |
12 |
(25) |
10 |
25 |
9 |
(13) |
|
|
Flixotide/Flovent |
189 |
1 |
97 |
12 |
43 |
(5) |
8 |
33 |
41 |
(17) |
|
|
Seretide/Advair |
1,245 |
9 |
648 |
7 |
401 |
3 |
73 |
17 |
123 |
35 |
|
|
Serevent |
59 |
(21) |
18 |
(13) |
29 |
(18) |
1 |
- |
11 |
(33) |
|
|
Ventolin |
112 |
23 |
32 |
>100 |
36 |
3 |
24 |
- |
20 |
(5) |
|
|
Zyrtec |
17 |
63 |
- |
- |
- |
- |
3 |
- |
14 |
43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-virals |
537 |
21 |
328 |
21 |
72 |
40 |
52 |
16 |
85 |
10 |
|
|
Hepsera |
29 |
9 |
- |
- |
- |
- |
13 |
- |
16 |
8 |
|
|
Relenza |
60 |
>100 |
19 |
>100 |
25 |
>100 |
4 |
- |
12 |
- |
|
|
Valtrex |
379 |
9 |
291 |
16 |
39 |
(3) |
6 |
20 |
43 |
(20) |
|
|
Zeffix |
55 |
(4) |
5 |
(25) |
8 |
17 |
29 |
10 |
13 |
(25) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Central nervous system |
449 |
(53) |
142 |
(79) |
144 |
(8) |
47 |
19 |
116 |
(2) |
|
|
Imigran/Imitrex |
68 |
(65) |
33 |
(79) |
23 |
(13) |
1 |
- |
11 |
- |
|
|
Lamictal |
103 |
(73) |
45 |
(86) |
38 |
(8) |
12 |
10 |
8 |
(29) |
|
|
Requip |
51 |
(22) |
6 |
(78) |
35 |
3 |
1 |
- |
9 |
- |
|
|
Seroxat/Paxil |
138 |
(13) |
13 |
(31) |
27 |
(19) |
21 |
13 |
77 |
(13) |
|
|
Treximet |
12 |
25 |
12 |
25 |
- |
- |
- |
- |
- |
- |
|
|
Wellbutrin |
30 |
(72) |
20 |
(81) |
7 |
100 |
2 |
50 |
1 |
(67) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiovascular and urogenital |
580 |
10 |
360 |
12 |
145 |
2 |
27 |
25 |
48 |
15 |
|
|
Arixtra |
61 |
39 |
33 |
63 |
23 |
24 |
2 |
100 |
3 |
(50) |
|
|
Avodart |
134 |
21 |
83 |
16 |
37 |
21 |
5 |
67 |
9 |
33 |
|
|
Coreg |
51 |
(9) |
50 |
(7) |
- |
- |
- |
- |
1 |
- |
|
|
Fraxiparine |
58 |
(9) |
- |
- |
43 |
(15) |
10 |
25 |
5 |
- |
|
|
Lovaza |
104 |
22 |
104 |
24 |
- |
- |
- |
- |
- |
- |
|
|
Vesicare |
26 |
31 |
26 |
31 |
- |
- |
- |
- |
- |
- |
|
|
Volibris |
4 |
- |
- |
- |
4 |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metabolic |
303 |
(12) |
149 |
(17) |
71 |
(11) |
32 |
4 |
51 |
(9) |
|
|
Avandia products |
198 |
(14) |
107 |
(19) |
46 |
(18) |
21 |
12 |
24 |
(4) |
|
|
Bonviva/Boniva |
66 |
(2) |
41 |
(11) |
23 |
6 |
1 |
- |
1 |
>100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-bacterials |
346 |
4 |
28 |
(1) |
139 |
(3) |
137 |
19 |
42 |
(10) |
|
|
Augmentin |
146 |
2 |
11 |
13 |
61 |
- |
59 |
13 |
15 |
(24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oncology and emesis |
166 |
19 |
88 |
19 |
50 |
12 |
14 |
27 |
14 |
38 |
|
|
Arzerra |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Hycamtin |
43 |
3 |
24 |
5 |
15 |
17 |
2 |
- |
2 |
- |
|
|
Promacta |
3 |
- |
3 |
- |
- |
- |
- |
- |
- |
- |
|
|
Tyverb/Tykerb |
41 |
64 |
17 |
18 |
18 |
88 |
6 |
>100 |
- |
- |
|
|
Votrient |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines |
756 |
14 |
196 |
22 |
320 |
7 |
145 |
8 |
95 |
42 |
|
|
Boostrix |
39 |
78 |
21 |
78 |
10 |
14 |
5 |
>100 |
3 |
>100 |
|
|
Cervarix |
73 |
>100 |
- |
- |
63 |
>100 |
4 |
>100 |
6 |
100 |
|
|
Fluarix, FluLaval |
14 |
>100 |
3 |
- |
- |
- |
9 |
33 |
2 |
- |
|
|
Flu Pandemic |
30 |
(26) |
25 |
- |
5 |
(86) |
- |
- |
- |
- |
|
|
Hepatitis |
195 |
(2) |
87 |
2 |
72 |
(8) |
22 |
(6) |
14 |
27 |
|
|
Infanrix, Pediarix |
154 |
(20) |
38 |
(43) |
91 |
(13) |
9 |
- |
16 |
(6) |
|
|
Rotarix |
71 |
69 |
22 |
- |
12 |
20 |
29 |
14 |
8 |
50 |
|
|
Synflorix |
12 |
- |
- |
- |
10 |
- |
- |
- |
2 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dermatologicals |
120 |
(2) |
22 |
(9) |
31 |
(3) |
38 |
5 |
29 |
(5) |
|
|
Bactroban |
32 |
- |
15 |
(6) |
7 |
(5) |
7 |
24 |
3 |
(3) |
|
|
Dermovate |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Duac |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Soriatane |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Zovirax |
33 |
(4) |
4 |
33 |
8 |
- |
7 |
- |
14 |
(17) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
208 |
(1) |
2 |
>100 |
66 |
1 |
68 |
8 |
72 |
(18) |
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
5,199 |
(3) |
2,140 |
(15) |
1,588 |
2 |
693 |
14 |
778 |
7 |
|
|
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
ViiV Healthcare (HIV) |
379 |
(10) |
164 |
(8) |
155 |
(14) |
24 |
(4) |
36 |
(6) |
|
|
Combivir |
102 |
(17) |
44 |
(15) |
37 |
(25) |
11 |
(8) |
10 |
- |
|
|
Epivir |
31 |
(24) |
11 |
(18) |
12 |
(33) |
3 |
(50) |
5 |
25 |
|
|
Epzicom/Kivexa |
129 |
6 |
50 |
- |
59 |
- |
5 |
100 |
15 |
44 |
|
|
Lexiva |
43 |
(8) |
23 |
6 |
16 |
(13) |
2 |
100 |
2 |
- |
|
|
Selzentry |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Trizivir |
48 |
(18) |
25 |
(13) |
20 |
(25) |
1 |
- |
2 |
- |
|
|
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
5,578 |
(4) |
|
|
|
|
|
|
|
|
|
|
|
------ |
------ |
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals turnover |
|
|||||||||||
Three months ended 31st March 2009 |
|
|||||||||||
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
|||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
|
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
|
Respiratory |
1,735 |
1 |
844 |
(1) |
546 |
(1) |
115 |
16 |
230 |
6 |
|
|
Avamys/Veramyst |
31 |
85 |
20 |
17 |
9 |
>100 |
1 |
- |
1 |
- |
|
|
Flixonase/Flonase |
69 |
11 |
10 |
100 |
12 |
(23) |
8 |
- |
39 |
17 |
|
|
Flixotide/Flovent |
195 |
(6) |
99 |
(4) |
48 |
(2) |
8 |
- |
40 |
(14) |
|
|
Seretide/Advair |
1,214 |
- |
653 |
(5) |
394 |
- |
65 |
27 |
102 |
26 |
|
|
Serevent |
62 |
(24) |
19 |
(18) |
31 |
(22) |
1 |
- |
11 |
(42) |
|
|
Ventolin |
116 |
23 |
38 |
>100 |
37 |
(3) |
22 |
6 |
19 |
(16) |
|
|
Zyrtec |
18 |
9 |
- |
- |
- |
- |
1 |
- |
17 |
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-virals |
666 |
44 |
288 |
7 |
163 |
>100 |
47 |
(3) |
168 |
43 |
|
|
Hepsera |
27 |
5 |
- |
- |
- |
- |
13 |
- |
14 |
1 |
|
|
Relenza |
222 |
>100 |
11 |
- |
110 |
- |
- |
- |
101 |
>100 |
|
|
Valtrex |
344 |
2 |
257 |
8 |
42 |
- |
6 |
- |
39 |
(19) |
|
|
Zeffix |
53 |
(13) |
4 |
- |
7 |
(14) |
28 |
(13) |
14 |
(15) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Central nervous system |
499 |
(53) |
216 |
(73) |
145 |
(2) |
42 |
6 |
96 |
(7) |
|
|
Imigran/Imitrex |
64 |
(68) |
28 |
(83) |
25 |
(4) |
1 |
- |
10 |
- |
|
|
Lamictal |
144 |
(61) |
86 |
(74) |
39 |
3 |
13 |
22 |
6 |
(25) |
|
|
Requip |
50 |
(56) |
8 |
(90) |
32 |
(3) |
- |
- |
10 |
40 |
|
|
Seroxat/Paxil |
126 |
(21) |
14 |
(61) |
28 |
(14) |
17 |
- |
67 |
(4) |
|
|
Treximet |
14 |
- |
14 |
- |
- |
- |
- |
- |
- |
- |
|
|
Wellbutrin |
64 |
(63) |
54 |
(68) |
6 |
67 |
2 |
- |
2 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiovascular and urogenital |
551 |
6 |
344 |
7 |
141 |
2 |
24 |
25 |
42 |
3 |
|
|
Arixtra |
59 |
29 |
33 |
26 |
22 |
29 |
1 |
- |
3 |
- |
|
|
Avodart |
122 |
12 |
73 |
8 |
36 |
7 |
5 |
33 |
8 |
60 |
|
|
Coreg |
51 |
(23) |
51 |
(23) |
- |
- |
- |
- |
- |
- |
|
|
Fraxiparine |
55 |
(8) |
- |
- |
43 |
(10) |
9 |
- |
3 |
- |
|
|
Lovaza |
106 |
54 |
105 |
52 |
- |
- |
- |
- |
1 |
- |
|
|
Vesicare |
24 |
21 |
24 |
21 |
- |
- |
- |
- |
- |
- |
|
|
Volibris |
2 |
- |
- |
- |
2 |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metabolic |
294 |
(16) |
150 |
(18) |
68 |
(21) |
28 |
9 |
48 |
(16) |
|
|
Avandia products |
197 |
(19) |
112 |
(18) |
43 |
(30) |
18 |
8 |
24 |
(16) |
|
|
Bonviva/Boniva |
62 |
(4) |
38 |
(15) |
21 |
20 |
- |
- |
3 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-bacterials |
393 |
(1) |
29 |
(30) |
183 |
(7) |
141 |
20 |
40 |
(8) |
|
|
Augmentin |
186 |
- |
16 |
(29) |
84 |
(9) |
67 |
29 |
19 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oncology and emesis |
144 |
1 |
70 |
(12) |
51 |
16 |
12 |
25 |
11 |
- |
|
|
Arzerra |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Hycamtin |
43 |
10 |
26 |
6 |
15 |
9 |
1 |
- |
1 |
- |
|
|
Promacta |
2 |
- |
2 |
- |
- |
- |
- |
- |
- |
- |
|
|
Tyverb/Tykerb |
34 |
42 |
11 |
(20) |
17 |
>100 |
3 |
>100 |
3 |
- |
|
|
Votrient |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines |
625 |
18 |
119 |
(21) |
286 |
23 |
131 |
75 |
89 |
18 |
|
|
Boostrix |
26 |
62 |
11 |
60 |
8 |
40 |
1 |
- |
6 |
67 |
|
|
Cervarix |
48 |
>100 |
- |
- |
39 |
>100 |
6 |
>100 |
3 |
>100 |
|
|
Fluarix, FluLaval |
6 |
- |
- |
- |
- |
- |
5 |
- |
1 |
- |
|
|
Flu Pandemic |
6 |
20 |
- |
- |
5 |
25 |
- |
- |
1 |
- |
|
|
Hepatitis |
149 |
(12) |
52 |
(28) |
61 |
(5) |
18 |
25 |
18 |
(11) |
|
|
Infanrix, Pediarix |
175 |
(5) |
39 |
(41) |
109 |
14 |
12 |
43 |
15 |
- |
|
|
Rotarix |
57 |
74 |
15 |
- |
13 |
22 |
24 |
40 |
5 |
33 |
|
|
Synflorix |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dermatologicals |
112 |
(1) |
23 |
15 |
31 |
(6) |
36 |
2 |
22 |
(13) |
|
|
Bactroban |
30 |
(5) |
15 |
(14) |
6 |
(5) |
7 |
21 |
2 |
(11) |
|
|
Dermovate |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Duac |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Soriatane |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Zovirax |
31 |
4 |
5 |
>100 |
8 |
(13) |
6 |
- |
12 |
(18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
180 |
(29) |
5 |
- |
55 |
(8) |
63 |
2 |
57 |
(59) |
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
5,199 |
(6) |
2,088 |
(24) |
1,669 |
9 |
639 |
20 |
803 |
(3) |
|
|
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
ViiV Healthcare (HIV) |
419 |
(8) |
195 |
(8) |
169 |
(9) |
19 |
(24) |
36 |
7 |
|
|
Combivir |
112 |
(16) |
53 |
(16) |
41 |
(17) |
9 |
(20) |
9 |
(13) |
|
|
Epivir |
34 |
(21) |
13 |
(18) |
14 |
(20) |
2 |
(33) |
5 |
(20) |
|
|
Epzicom/Kivexa |
137 |
10 |
58 |
5 |
62 |
10 |
3 |
>100 |
14 |
10 |
|
|
Lexiva |
48 |
6 |
27 |
6 |
17 |
(7) |
1 |
- |
3 |
>100 |
|
|
Selzentry |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Trizivir |
56 |
(20) |
30 |
(22) |
24 |
(17) |
1 |
- |
1 |
(50) |
|
|
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
5,618 |
(6) |
|
|
|
|
|
|
|
|
|
|
|
------ |
------ |
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals turnover |
|
|||||||||||
Three months ended 31st December 2008 |
|
|||||||||||
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
|||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
|
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
|
Respiratory |
1,731 |
7 |
852 |
9 |
550 |
3 |
116 |
19 |
213 |
1 |
|
|
Avamys/Veramyst |
25 |
>100 |
18 |
75 |
6 |
- |
1 |
- |
- |
- |
|
|
Flixonase/Flonase |
42 |
9 |
8 |
>100 |
12 |
(17) |
8 |
14 |
14 |
(17) |
|
|
Flixotide/Flovent |
208 |
(1) |
103 |
2 |
50 |
2 |
9 |
14 |
46 |
(14) |
|
|
Seretide/Advair |
1,237 |
8 |
674 |
6 |
392 |
5 |
62 |
22 |
109 |
36 |
|
|
Serevent |
70 |
(18) |
22 |
(5) |
33 |
(17) |
1 |
100 |
14 |
(44) |
|
|
Ventolin |
104 |
12 |
23 |
>100 |
40 |
9 |
23 |
5 |
18 |
(32) |
|
|
Zyrtec |
12 |
(7) |
- |
- |
- |
- |
1 |
- |
11 |
(11) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-virals |
476 |
(4) |
303 |
4 |
51 |
7 |
46 |
19 |
76 |
(37) |
|
|
Hepsera |
27 |
20 |
- |
- |
- |
- |
12 |
25 |
15 |
8 |
|
|
Relenza |
13 |
(85) |
5 |
(93) |
5 |
25 |
- |
- |
3 |
(90) |
|
|
Valtrex |
366 |
16 |
279 |
24 |
38 |
3 |
6 |
75 |
43 |
(18) |
|
|
Zeffix |
53 |
2 |
4 |
33 |
7 |
(17) |
26 |
17 |
16 |
(13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Central nervous system |
665 |
(43) |
353 |
(61) |
151 |
- |
41 |
6 |
120 |
(5) |
|
|
Imigran/Imitrex |
161 |
(34) |
123 |
(40) |
25 |
(4) |
1 |
- |
12 |
(22) |
|
|
Lamictal |
177 |
(57) |
119 |
(68) |
39 |
(8) |
12 |
11 |
7 |
(14) |
|
|
Requip |
58 |
(53) |
11 |
(92) |
38 |
28 |
- |
- |
9 |
33 |
|
|
Seroxat/Paxil |
154 |
(21) |
19 |
(67) |
29 |
(10) |
19 |
7 |
87 |
(4) |
|
|
Treximet |
13 |
- |
13 |
- |
- |
- |
- |
- |
- |
- |
|
|
Wellbutrin |
66 |
(63) |
56 |
(69) |
6 |
>100 |
2 |
- |
2 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiovascular and urogenital |
548 |
51 |
344 |
>100 |
137 |
5 |
23 |
31 |
44 |
8 |
|
|
Arixtra |
55 |
59 |
31 |
63 |
21 |
64 |
1 |
- |
2 |
(50) |
|
|
Avodart |
120 |
19 |
75 |
22 |
33 |
12 |
4 |
100 |
8 |
- |
|
|
Coreg |
61 |
>100 |
60 |
>100 |
- |
- |
- |
- |
- |
- |
|
|
Fraxiparine |
58 |
(2) |
- |
- |
44 |
(10) |
10 |
50 |
4 |
- |
|
|
Lovaza |
98 |
>100 |
98 |
>100 |
- |
- |
- |
- |
- |
- |
|
|
Vesicare |
23 |
36 |
23 |
36 |
- |
- |
- |
- |
- |
- |
|
|
Volibris |
1 |
- |
- |
- |
1 |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metabolic |
345 |
(11) |
182 |
(13) |
76 |
(16) |
32 |
4 |
55 |
(6) |
|
|
Avandia products |
229 |
(17) |
132 |
(21) |
47 |
(27) |
22 |
11 |
28 |
- |
|
|
Bonviva/Boniva |
76 |
23 |
51 |
8 |
23 |
33 |
1 |
- |
1 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-bacterials |
361 |
(7) |
31 |
(27) |
172 |
(9) |
120 |
5 |
38 |
(14) |
|
|
Augmentin |
159 |
(5) |
15 |
(13) |
74 |
(6) |
52 |
- |
18 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oncology and emesis |
138 |
12 |
64 |
11 |
50 |
16 |
11 |
25 |
13 |
(10) |
|
|
Arzerra |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Hycamtin |
41 |
10 |
25 |
18 |
14 |
- |
1 |
100 |
1 |
(50) |
|
|
Promacta |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Tyverb/Tykerb |
35 |
58 |
14 |
(8) |
17 |
>100 |
4 |
>100 |
- |
- |
|
|
Votrient |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines |
796 |
8 |
178 |
(31) |
356 |
23 |
172 |
51 |
90 |
8 |
|
|
Boostrix |
17 |
- |
8 |
- |
7 |
20 |
- |
- |
2 |
(50) |
|
|
Cervarix |
55 |
>100 |
- |
- |
45 |
>100 |
7 |
- |
3 |
- |
|
|
Fluarix, FluLaval |
66 |
12 |
22 |
(27) |
21 |
89 |
13 |
>100 |
10 |
(21) |
|
|
Flu Pandemic |
17 |
(86) |
1 |
(99) |
15 |
(68) |
- |
- |
1 |
- |
|
|
Hepatitis |
185 |
5 |
74 |
6 |
74 |
- |
20 |
21 |
17 |
13 |
|
|
Infanrix, Pediarix |
194 |
19 |
56 |
- |
113 |
36 |
9 |
(11) |
16 |
9 |
|
|
Rotarix |
66 |
59 |
17 |
- |
13 |
57 |
32 |
- |
4 |
>100 |
|
|
Synflorix |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dermatologicals |
113 |
(2) |
23 |
(5) |
30 |
(8) |
31 |
7 |
29 |
- |
|
|
Bactroban |
31 |
(7) |
15 |
(20) |
7 |
(14) |
5 |
- |
4 |
>100 |
|
|
Dermovate |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Duac |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Soriatane |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Zovirax |
31 |
(4) |
4 |
67 |
8 |
(13) |
5 |
- |
14 |
(17) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
213 |
(14) |
3 |
(94) |
88 |
28 |
60 |
(5) |
62 |
(19) |
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
5,386 |
(4) |
2,333 |
(14) |
1,661 |
6 |
652 |
18 |
740 |
(8) |
|
|
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
ViiV Healthcare (HIV) |
417 |
(3) |
193 |
(1) |
165 |
(10) |
25 |
10 |
34 |
7 |
|
|
Combivir |
114 |
(13) |
53 |
(4) |
42 |
(18) |
10 |
- |
9 |
(40) |
|
|
Epivir |
36 |
(22) |
14 |
(15) |
15 |
(20) |
1 |
(33) |
6 |
(33) |
|
|
Epzicom/Kivexa |
129 |
20 |
55 |
19 |
57 |
16 |
5 |
>100 |
12 |
11 |
|
|
Lexiva |
47 |
6 |
26 |
11 |
15 |
(7) |
5 |
>100 |
1 |
- |
|
|
Selzentry |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Trizivir |
59 |
(14) |
32 |
(11) |
22 |
(24) |
2 |
100 |
3 |
- |
|
|
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
5,803 |
(4) |
|
|
|
|
|
|
|
|
|
|
|
------ |
------ |
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals turnover |
|
|||||||||||
Three months ended 30th September 2008 |
|
|||||||||||
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
|||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
|
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
|
Respiratory |
1,348 |
3 |
636 |
3 |
449 |
- |
92 |
11 |
171 |
11 |
|
|
Avamys/Veramyst |
17 |
>100 |
12 |
>100 |
3 |
- |
- |
- |
2 |
- |
|
|
Flixonase/Flonase |
33 |
(39) |
7 |
(67) |
11 |
11 |
8 |
17 |
7 |
(54) |
|
|
Flixotide/Flovent |
149 |
(4) |
71 |
(1) |
38 |
(3) |
6 |
20 |
34 |
(12) |
|
|
Seretide/Advair |
982 |
7 |
515 |
5 |
324 |
1 |
51 |
18 |
92 |
46 |
|
|
Serevent |
60 |
(14) |
17 |
(11) |
32 |
(13) |
1 |
- |
10 |
(9) |
|
|
Ventolin |
78 |
6 |
9 |
60 |
31 |
- |
17 |
- |
21 |
6 |
|
|
Zyrtec |
7 |
(15) |
- |
- |
- |
- |
1 |
- |
6 |
(20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-virals |
391 |
9 |
242 |
20 |
42 |
(26) |
33 |
- |
74 |
10 |
|
|
Hepsera |
20 |
6 |
- |
- |
- |
- |
8 |
17 |
12 |
- |
|
|
Relenza |
12 |
(57) |
5 |
(58) |
- |
- |
- |
- |
7 |
>100 |
|
|
Valtrex |
303 |
21 |
223 |
28 |
35 |
7 |
6 |
- |
39 |
3 |
|
|
Zeffix |
42 |
(10) |
4 |
(25) |
7 |
- |
20 |
(11) |
11 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Central nervous system |
585 |
(38) |
321 |
(52) |
142 |
4 |
37 |
6 |
85 |
(10) |
|
|
Imigran/Imitrex |
188 |
5 |
154 |
8 |
24 |
(5) |
1 |
- |
9 |
- |
|
|
Lamictal |
136 |
(59) |
84 |
(71) |
37 |
(9) |
10 |
13 |
5 |
(13) |
|
|
Requip |
56 |
(43) |
13 |
(81) |
35 |
35 |
1 |
- |
7 |
40 |
|
|
Seroxat/Paxil |
112 |
(23) |
13 |
(67) |
27 |
(8) |
16 |
8 |
56 |
(13) |
|
|
Treximet |
4 |
- |
4 |
- |
- |
- |
- |
- |
- |
- |
|
|
Wellbutrin |
53 |
(67) |
44 |
(72) |
6 |
100 |
2 |
- |
1 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiovascular and urogenital |
466 |
12 |
280 |
9 |
130 |
17 |
21 |
36 |
35 |
3 |
|
|
Arixtra |
44 |
56 |
22 |
43 |
19 |
78 |
1 |
- |
2 |
100 |
|
|
Avodart |
102 |
29 |
63 |
29 |
29 |
19 |
4 |
50 |
6 |
75 |
|
|
Coreg |
50 |
(69) |
49 |
(69) |
- |
- |
- |
- |
1 |
- |
|
|
Fraxiparine |
59 |
22 |
- |
- |
47 |
18 |
10 |
50 |
2 |
- |
|
|
Lovaza |
75 |
- |
75 |
- |
- |
- |
- |
- |
- |
- |
|
|
Vesicare |
18 |
31 |
18 |
31 |
- |
- |
- |
- |
- |
- |
|
|
Volibris |
1 |
- |
- |
- |
1 |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metabolic |
289 |
(11) |
136 |
(22) |
72 |
(2) |
33 |
35 |
48 |
(10) |
|
|
Avandia products |
191 |
(23) |
99 |
(28) |
48 |
(16) |
17 |
7 |
27 |
(26) |
|
|
Bonviva/Boniva |
56 |
24 |
36 |
18 |
18 |
60 |
- |
- |
2 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-bacterials |
306 |
1 |
21 |
(19) |
133 |
(3) |
114 |
11 |
38 |
3 |
|
|
Augmentin |
143 |
10 |
9 |
(36) |
62 |
6 |
56 |
26 |
16 |
15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oncology and emesis |
128 |
12 |
64 |
13 |
41 |
6 |
10 |
- |
13 |
30 |
|
|
Arzerra |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Hycamtin |
34 |
3 |
20 |
- |
12 |
10 |
1 |
- |
1 |
- |
|
|
Promacta |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Tyverb/Tykerb |
26 |
44 |
12 |
- |
10 |
80 |
2 |
- |
2 |
- |
|
|
Votrient |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines |
730 |
12 |
218 |
(13) |
323 |
40 |
114 |
10 |
75 |
(11) |
|
|
Boostrix |
22 |
(19) |
13 |
(40) |
7 |
40 |
- |
- |
2 |
100 |
|
|
Cervarix |
43 |
>100 |
- |
- |
38 |
- |
2 |
- |
3 |
>100 |
|
|
Fluarix, FluLaval |
144 |
11 |
63 |
(19) |
58 |
55 |
12 |
100 |
11 |
100 |
|
|
Flu Pandemic |
10 |
(52) |
- |
- |
10 |
>100 |
- |
- |
- |
- |
|
|
Hepatitis |
174 |
11 |
82 |
17 |
61 |
2 |
16 |
40 |
15 |
- |
|
|
Infanrix, Pediarix |
168 |
9 |
56 |
(10) |
89 |
23 |
10 |
14 |
13 |
36 |
|
|
Rotarix |
39 |
57 |
4 |
- |
11 |
67 |
19 |
29 |
5 |
33 |
|
|
Synflorix |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dermatologicals |
102 |
2 |
22 |
(5) |
30 |
4 |
32 |
7 |
18 |
(10) |
|
|
Bactroban |
29 |
8 |
14 |
(8) |
7 |
40 |
6 |
50 |
2 |
(50) |
|
|
Dermovate |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Duac |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Soriatane |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Zovirax |
25 |
(19) |
3 |
(50) |
7 |
(29) |
5 |
- |
10 |
(9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
166 |
(5) |
8 |
- |
51 |
(10) |
52 |
(15) |
55 |
(17) |
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
4,511 |
(4) |
1,948 |
(13) |
1,413 |
7 |
538 |
8 |
612 |
(1) |
|
|
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
ViiV Healthcare (HIV) |
377 |
(5) |
153 |
(11) |
150 |
(6) |
43 |
21 |
31 |
- |
|
|
Combivir |
110 |
(13) |
41 |
(26) |
38 |
(19) |
21 |
40 |
10 |
- |
|
|
Epivir |
35 |
(16) |
11 |
(29) |
13 |
(27) |
7 |
20 |
4 |
25 |
|
|
Epzicom/Kivexa |
110 |
24 |
44 |
21 |
50 |
19 |
3 |
>100 |
13 |
38 |
|
|
Lexiva |
40 |
(3) |
21 |
(5) |
15 |
(8) |
2 |
- |
2 |
50 |
|
|
Selzentry |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Trizivir |
49 |
(20) |
24 |
(21) |
22 |
(17) |
1 |
(67) |
2 |
100 |
|
|
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
4,888 |
(4) |
|
|
|
|
|
|
|
|
|
|
|
------ |
------ |
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals turnover |
|
|||||||||||
Three months ended 30th June 2008 |
|
|||||||||||
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
|||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
|
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
|
Respiratory |
1,383 |
4 |
616 |
4 |
497 |
- |
100 |
22 |
170 |
1 |
|
|
Avamys/Veramyst |
17 |
89 |
14 |
56 |
1 |
- |
- |
- |
2 |
- |
|
|
Flixonase/Flonase |
65 |
13 |
33 |
32 |
16 |
(13) |
8 |
- |
8 |
13 |
|
|
Flixotide/Flovent |
158 |
(3) |
68 |
5 |
43 |
(7) |
6 |
(14) |
41 |
(10) |
|
|
Seretide/Advair |
964 |
6 |
473 |
2 |
356 |
6 |
58 |
46 |
77 |
9 |
|
|
Serevent |
66 |
(11) |
16 |
(11) |
34 |
(11) |
1 |
(50) |
15 |
(13) |
|
|
Ventolin |
80 |
6 |
7 |
40 |
33 |
(3) |
21 |
12 |
19 |
6 |
|
|
Zyrtec |
8 |
(10) |
- |
- |
- |
- |
1 |
- |
7 |
(14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-virals |
361 |
(5) |
210 |
2 |
47 |
(37) |
37 |
6 |
67 |
- |
|
|
Hepsera |
22 |
25 |
- |
- |
- |
- |
9 |
29 |
13 |
30 |
|
|
Relenza |
3 |
(97) |
2 |
(94) |
1 |
(96) |
- |
- |
- |
- |
|
|
Valtrex |
277 |
19 |
195 |
22 |
36 |
10 |
5 |
- |
41 |
16 |
|
|
Zeffix |
47 |
- |
4 |
33 |
6 |
20 |
21 |
- |
16 |
(13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Central nervous system |
818 |
(4) |
547 |
(6) |
143 |
1 |
36 |
3 |
92 |
(1) |
|
|
Imigran/Imitrex |
173 |
2 |
139 |
2 |
24 |
- |
1 |
- |
9 |
- |
|
|
Lamictal |
323 |
18 |
268 |
22 |
38 |
(3) |
10 |
25 |
7 |
(38) |
|
|
Requip |
58 |
(37) |
18 |
(69) |
31 |
27 |
1 |
- |
8 |
>100 |
|
|
Seroxat/Paxil |
127 |
(18) |
16 |
(47) |
31 |
(13) |
16 |
(6) |
64 |
(7) |
|
|
Treximet |
8 |
- |
8 |
- |
- |
- |
- |
- |
- |
- |
|
|
Wellbutrin |
97 |
(27) |
89 |
(30) |
3 |
- |
2 |
100 |
3 |
(33) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiovascular and urogenital |
435 |
(5) |
251 |
(14) |
129 |
12 |
20 |
36 |
35 |
6 |
|
|
Arixtra |
36 |
31 |
16 |
21 |
17 |
50 |
1 |
- |
2 |
(50) |
|
|
Avodart |
92 |
33 |
55 |
38 |
28 |
19 |
3 |
100 |
6 |
25 |
|
|
Coreg |
44 |
(78) |
43 |
(78) |
- |
- |
- |
- |
1 |
- |
|
|
Fraxiparine |
58 |
13 |
- |
- |
46 |
3 |
8 |
17 |
4 |
>100 |
|
|
Lovaza |
67 |
- |
66 |
- |
- |
- |
- |
- |
1 |
- |
|
|
Vesicare |
16 |
25 |
16 |
25 |
- |
- |
- |
- |
- |
- |
|
|
Volibris |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metabolic |
285 |
(35) |
139 |
(44) |
73 |
(19) |
27 |
(17) |
46 |
(27) |
|
|
Avandia products |
194 |
(46) |
104 |
(54) |
49 |
(31) |
17 |
(24) |
24 |
(39) |
|
|
Bonviva/Boniva |
56 |
47 |
36 |
38 |
18 |
60 |
1 |
- |
1 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-bacterials |
298 |
(1) |
22 |
(31) |
133 |
(3) |
104 |
11 |
39 |
- |
|
|
Augmentin |
129 |
(1) |
8 |
(47) |
57 |
- |
48 |
13 |
16 |
15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oncology and emesis |
117 |
(11) |
57 |
(24) |
41 |
6 |
11 |
38 |
8 |
(11) |
|
|
Arzerra |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Hycamtin |
35 |
18 |
19 |
19 |
12 |
- |
2 |
- |
2 |
>100 |
|
|
Promacta |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Tyverb/Tykerb |
22 |
75 |
11 |
20 |
8 |
>100 |
2 |
- |
1 |
- |
|
|
Votrient |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines |
577 |
34 |
124 |
19 |
276 |
41 |
115 |
67 |
62 |
- |
|
|
Boostrix |
18 |
21 |
9 |
29 |
7 |
20 |
1 |
- |
1 |
(50) |
|
|
Cervarix |
15 |
- |
- |
- |
11 |
- |
2 |
- |
2 |
- |
|
|
Fluarix, FluLaval |
5 |
25 |
- |
- |
(1) |
- |
6 |
25 |
- |
- |
|
|
Flu Pandemic |
34 |
- |
- |
- |
35 |
- |
- |
- |
(1) |
- |
|
|
Hepatitis |
167 |
23 |
66 |
43 |
72 |
3 |
18 |
70 |
11 |
8 |
|
|
Infanrix, Pediarix |
167 |
13 |
49 |
(4) |
94 |
26 |
8 |
14 |
16 |
17 |
|
|
Rotarix |
35 |
>100 |
- |
- |
10 |
33 |
21 |
>100 |
4 |
- |
|
|
Synflorix |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dermatologicals |
105 |
2 |
20 |
11 |
30 |
4 |
32 |
14 |
23 |
(17) |
|
|
Bactroban |
27 |
4 |
13 |
8 |
7 |
20 |
5 |
- |
2 |
(33) |
|
|
Dermovate |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Duac |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Soriatane |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Zovirax |
28 |
- |
3 |
>100 |
7 |
- |
6 |
- |
12 |
(15) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
183 |
(8) |
1 |
(67) |
65 |
25 |
57 |
(3) |
60 |
(28) |
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
4,562 |
(1) |
1,987 |
(8) |
1,434 |
6 |
539 |
17 |
602 |
(6) |
|
|
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
ViiV Healthcare (HIV) |
361 |
(6) |
142 |
(10) |
164 |
(2) |
24 |
(20) |
31 |
4 |
|
|
Combivir |
104 |
(15) |
41 |
(18) |
44 |
(19) |
12 |
(15) |
7 |
13 |
|
|
Epivir |
34 |
(20) |
11 |
(8) |
15 |
(19) |
4 |
(33) |
4 |
(33) |
|
|
Epzicom/Kivexa |
104 |
24 |
39 |
6 |
54 |
33 |
2 |
100 |
9 |
67 |
|
|
Lexiva |
38 |
9 |
18 |
- |
16 |
8 |
1 |
- |
3 |
- |
|
|
Selzentry |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Trizivir |
50 |
(23) |
23 |
(25) |
24 |
(13) |
1 |
(50) |
2 |
(67) |
|
|
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
4,923 |
(2) |
|
|
|
|
|
|
|
|
|
|
|
------ |
------ |
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals turnover |
|
|||||||||||
Three months ended 31st March 2008 |
|
|||||||||||
|
Total |
USA |
Europe |
Emerging Markets |
Rest of World |
|||||||
|
--------------------- |
--------------------- |
-------------------- |
-------------------------- |
--------------------- |
|
||||||
|
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
£m |
CER% |
|
|
|
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
-------- |
------------ |
|
|
Respiratory |
1,355 |
6 |
616 |
8 |
486 |
4 |
85 |
10 |
168 |
4 |
|
|
Avamys/Veramyst |
13 |
- |
12 |
- |
1 |
- |
- |
- |
- |
- |
|
|
Flixonase/Flonase |
46 |
(33) |
4 |
(84) |
13 |
- |
6 |
20 |
23 |
(5) |
|
|
Flixotide/Flovent |
162 |
(1) |
75 |
7 |
44 |
(7) |
7 |
20 |
36 |
(11) |
|
|
Seretide/Advair |
954 |
10 |
499 |
10 |
345 |
8 |
44 |
17 |
66 |
20 |
|
|
Serevent |
67 |
(5) |
17 |
(11) |
37 |
6 |
1 |
- |
12 |
(23) |
|
|
Ventolin |
77 |
9 |
7 |
>100 |
33 |
- |
18 |
- |
19 |
13 |
|
|
Zyrtec |
11 |
1 |
- |
- |
- |
- |
1 |
- |
10 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-virals |
356 |
(9) |
194 |
(10) |
44 |
(40) |
36 |
30 |
82 |
6 |
|
|
Hepsera |
20 |
20 |
- |
- |
- |
- |
9 |
33 |
11 |
10 |
|
|
Relenza |
29 |
(71) |
8 |
(82) |
- |
- |
- |
- |
21 |
19 |
|
|
Valtrex |
249 |
9 |
173 |
7 |
35 |
15 |
5 |
67 |
36 |
7 |
|
|
Zeffix |
46 |
8 |
3 |
- |
7 |
- |
23 |
24 |
13 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Central nervous system |
829 |
3 |
594 |
7 |
129 |
(8) |
33 |
3 |
73 |
(11) |
|
|
Imigran/Imitrex |
165 |
(1) |
134 |
- |
23 |
(5) |
1 |
- |
7 |
(13) |
|
|
Lamictal |
290 |
16 |
240 |
22 |
33 |
(14) |
9 |
13 |
8 |
- |
|
|
Requip |
94 |
15 |
60 |
9 |
29 |
24 |
- |
- |
5 |
67 |
|
|
Seroxat/Paxil |
121 |
(15) |
31 |
(16) |
28 |
(24) |
14 |
- |
48 |
(12) |
|
|
Treximet |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Wellbutrin |
126 |
(3) |
121 |
(4) |
3 |
>100 |
1 |
(50) |
1 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cardiovascular and urogenital |
398 |
(12) |
232 |
(22) |
116 |
6 |
16 |
7 |
34 |
24 |
|
|
Arixtra |
35 |
70 |
19 |
73 |
14 |
33 |
- |
- |
2 |
- |
|
|
Avodart |
85 |
30 |
49 |
22 |
28 |
39 |
3 |
100 |
5 |
67 |
|
|
Coreg |
48 |
(77) |
48 |
(78) |
- |
- |
- |
- |
- |
(50) |
|
|
Fraxiparine |
51 |
(4) |
- |
- |
41 |
(8) |
7 |
17 |
3 |
- |
|
|
Lovaza |
50 |
- |
50 |
- |
- |
- |
- |
- |
- |
- |
|
|
Vesicare |
14 |
36 |
14 |
36 |
- |
- |
- |
- |
- |
- |
|
|
Volibris |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metabolic |
272 |
(45) |
133 |
(57) |
73 |
(6) |
22 |
(28) |
44 |
(31) |
|
|
Avandia products |
191 |
(56) |
99 |
(66) |
54 |
(14) |
13 |
(43) |
25 |
(45) |
|
|
Bonviva/Boniva |
49 |
50 |
33 |
48 |
15 |
44 |
- |
- |
1 |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anti-bacterials |
336 |
(4) |
30 |
(26) |
169 |
(8) |
100 |
16 |
37 |
(3) |
|
|
Augmentin |
156 |
(1) |
17 |
(29) |
79 |
- |
45 |
19 |
15 |
(13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oncology and emesis |
113 |
(27) |
58 |
(41) |
37 |
6 |
8 |
17 |
10 |
(10) |
|
|
Arzerra |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Hycamtin |
30 |
(3) |
17 |
(5) |
11 |
11 |
1 |
- |
1 |
- |
|
|
Promacta |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Tyverb/Tykerb |
19 |
>100 |
10 |
>100 |
7 |
>100 |
1 |
- |
1 |
- |
|
|
Votrient |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vaccines |
436 |
10 |
109 |
34 |
200 |
5 |
61 |
(3) |
66 |
7 |
|
|
Boostrix |
13 |
(8) |
5 |
(29) |
5 |
- |
- |
- |
3 |
50 |
|
|
Cervarix |
12 |
- |
- |
- |
10 |
- |
1 |
- |
1 |
- |
|
|
Fluarix, FluLaval |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Flu Pandemic |
5 |
- |
- |
- |
4 |
- |
- |
- |
1 |
- |
|
|
Hepatitis |
139 |
16 |
53 |
66 |
56 |
(4) |
12 |
(8) |
18 |
- |
|
|
Infanrix, Pediarix |
153 |
6 |
51 |
21 |
81 |
(1) |
7 |
- |
14 |
- |
|
|
Rotarix |
27 |
79 |
- |
- |
9 |
100 |
15 |
56 |
3 |
>100 |
|
|
Synflorix |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dermatologicals |
94 |
1 |
16 |
23 |
29 |
(4) |
30 |
4 |
19 |
(10) |
|
|
Bactroban |
25 |
14 |
13 |
18 |
6 |
- |
5 |
- |
1 |
100 |
|
|
Dermovate |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Duac |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Soriatane |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Zovirax |
25 |
(15) |
1 |
(50) |
8 |
(13) |
5 |
- |
11 |
(18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
220 |
14 |
4 |
(91) |
56 |
27 |
57 |
- |
103 |
73 |
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
4,409 |
(4) |
1,986 |
(11) |
1,339 |
(1) |
448 |
6 |
636 |
6 |
|
|
|
|
|
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
ViiV Healthcare (HIV) |
358 |
(5) |
152 |
(6) |
157 |
(7) |
21 |
- |
28 |
9 |
|
|
Combivir |
105 |
(13) |
45 |
(8) |
42 |
(21) |
10 |
11 |
8 |
(25) |
|
|
Epivir |
34 |
(22) |
11 |
(21) |
15 |
(22) |
3 |
(40) |
5 |
- |
|
|
Epzicom/Kivexa |
99 |
25 |
40 |
17 |
48 |
33 |
1 |
>100 |
10 |
14 |
|
|
Lexiva |
35 |
(3) |
18 |
(10) |
15 |
8 |
1 |
- |
1 |
(50) |
|
|
Selzentry |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
Trizivir |
54 |
(16) |
27 |
(16) |
24 |
(19) |
1 |
- |
2 |
- |
|
|
|
-------- |
-------- |
-------- |
--------- |
-------- |
--------- |
-------- |
--------- |
-------- |
-------- |
|
|
|
4,767 |
(4) |
|
|
|
|
|
|
|
|
|
|
|
------ |
------ |
|
|
|
|
|
|
|
|
|
|
[End]